Benzinga - Tue, 24 Mar 2020 11:35:03 -0400
Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of genetic and vascular disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to several depigmentation disorders.

Related Companies

TickerCompanyChg %Mkt Cap
CLVLYClinuvel Pharmaceuticals-5.8%852.3M

Clinuvel Pharmaceuticals Company Questions & Answers

Q

How do I buy Clinuvel Pharmaceuticals (CLVLY) stock?

A

You can purchase shares of Clinuvel Pharmaceuticals (OTC: CLVLY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Clinuvel Pharmaceuticals's (CLVLY) main competitors?

A

There are no as such competitors for Clinuvel Pharmaceuticals.

Q

What is the target price for Clinuvel Pharmaceuticals?

A

There is no analysis for Clinuvel Pharmaceuticals

Q

How much is Clinuvel Pharmaceuticals (CLVLY) stock ?

A

The stock price for Clinuvel Pharmaceuticals (OTC: CLVLY) is $17.25 last updated Today at 6:51:37 PM.

Q

When is the next Clinuvel Pharmaceuticals (CLVLY) dividend?

A

There are no upcoming dividends for Clinuvel Pharmaceuticals. The last dividend paid out to investors was $0.00 on 2018-09-20.

Q

When is Clinuvel Pharmaceuticals (OTC:CLVLY) reporting earnings?

A

There are no earnings for Clinuvel Pharmaceuticals

Q

When is the upcoming split for CLVLY?

A

There is no upcoming split for Clinuvel Pharmaceuticals.